Volume 10, Number 8—August 2004
Research
Long-Term Prognosis for Clinical West Nile Virus Infection
Anne Labowitz Klee*, Beth Maldin*, Barbara Edwin*, Iqbal Poshni*, Farzad Mostashari*, Annie Fine*, Marcelle Layton*, and Denis Nash*†1
Table 6
Recovery at 12 months postonset by health status domain and underlying health condition in patients with clinical West Nile virus infection, New York City, 1999
| Recovery | Total | Recovered, n (%) | Not recovered, n (%) | Risk ratio | 95% confidence interval |
|---|---|---|---|---|---|
| Physical recovery | |||||
| No underlying condition | 18 | 11 (61.1) | 7 (38.9) | 1.3 | 0.70–2.4 |
| Hypertension or diabetes | 17 | 8 (47.1) | 9 (52.9) | Referent | |
| Total | 35 | 19 (54.3) | 16 (45.7) | ||
| Cognitive recovery | |||||
| No underlying condition | 17 | 11 (64.7) | 6 (35.3) | 1.2 | 0.70–2.2 |
| Hypertension or diabetes | 17 | 9 (52.9) | 8 (47.1) | Referent | |
| Total | 34 | 20 (58.8) | 14 (41.2) | ||
| Functional recovery | |||||
| No underlying condition | 18 | 12 (66.7) | 6 (33.3) | 1.4 | 0.78–2.6 |
| Hypertension or diabetes | 17 | 8 (47.1) | 9 (52.9) | Referent | |
| Total | 35 | 20 (57.1) | 15 (42.9) | ||
| Total recovery | |||||
| No underlying condition | 18 | 9 (50.0) | 9 (50.0) | 2.1 | 0.80–5.6 |
| Hypertension or diabetes | 17 | 4 (23.5) | 13 (76.5) | Referent | |
| Total | 35 | 13 (37.1) | 22 (62.9) |
